Biotech MapLight Jumps 8% in First US IPO Using Shutdown Fix
Pedestrians outside of the New York Stock Exchange.
Photographer: Michael Nagle/BloombergMapLight Therapeutics Inc. shares closed 8% higher in its trading debut after the biotechnology firm raised $258.9 million in an initial public offering and private placement.
Shares of the Redwood City, California-based firm ended at $18.34 each on Monday, above an IPO price of $17 apiece. The company sold 14.75 million shares Sunday, and affiliates of funds managed by Goldman Sachs Group Inc. bought 476,707 MapLight shares at the IPO price.